|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400091976 |
|
最近更新日期: Date of Last Refreshed on: |
2024-11-06 17:48:45 |
|
注册时间: Date of Registration: |
2024-11-06 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
基于ERAS理念探讨香山正骨养生功法对腰椎融合术后康复的临床研究 |
|
Public title: |
Clinical application of Xiangshan Zheng gu Training in rehabilitation after posterior lumbar interbody fusion based on the concept of Enhanced Recovery After Surgery |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
基于ERAS理念探讨香山正骨养生功法对腰椎融合术后康复的临床研究 |
|
Scientific title: |
Clinical application of Xiangshan Zheng gu Training in rehabilitation after posterior lumbar interbody fusion based on the concept of Enhanced Recovery After Surgery |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
陈鉴权 |
研究负责人: |
陈鉴权 |
|
Applicant: |
chenjianquan |
Study leader: |
chenjianquan |
|
申请注册联系人电话: Applicant telephone: |
+86 158 2057 7044 |
研究负责人电话: Study leader's telephone: |
+86 158 2057 7044 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
498553674@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
498553674@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
广东省珠海市香洲区景乐路53号,广东省中医院珠海医院 |
研究负责人通讯地址: |
广东省珠海市香洲区景乐路53号,广东省中医院珠海医院 |
|
Applicant address: |
No. 53, Jingle Road, Zhuhai, Guangdong, China Zhuhai Hospital of Guangdong Provincial Hospital of Traditional Chinese Medicine |
Study leader's address: |
No. 53, Jingle Road, Zhuhai, Guangdong, China Zhuhai Hospital of Guangdong Provincial Hospital of Traditional Chinese Medicine |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
广东省中医院珠海医院 |
||
|
Applicant's institution: |
Zhuhai Hospital of Guangdong Provincial Hospital of Traditional Chinese Medicine |
||
|
研究负责人所在单位: |
广东省中医院珠海医院 |
||
|
Affiliation of the Leader: |
Zhuhai Hospital of Guangdong Provincial Hospital of Traditional Chinese Medicine |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
BF2022-298-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
广东省中医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Guangdong Hospital of Traditional Chinese Medicine |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-12-23 00:00:00 |
||
|
伦理委员会联系人: |
张茜 |
||
|
Contact Name of the ethic committee: |
zhangqian |
||
|
伦理委员会联系地址: |
广东省广州市大德路111号 |
||
|
Contact Address of the ethic committee: |
No. 111, Dade Road, Guangzhou, Guangdong, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 137 0231 7625 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
广东省中医院珠海医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Zhuhai Hospital of Guangdong Provincial Hospital of Traditional Chinese Medicine |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
广东省珠海市香洲区景乐路53号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 53, Jingle Road, Zhuhai, Guangdong, China Zhuhai Hospital of Guangdong Provincial |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
Self-finance |
||||||||||||||||||||||
|
Target disease: |
Lumbar disease |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
探讨香山正骨养生功法对腰椎后路融合术后患者功能康复及其生活质量的影响 |
||||||||||||||||||||||
|
Objectives of Study: |
Exploring the effects of Xiangshan orthopedic bone regeneration gong method on functional rehabilitation and its quality of life of patients after posterior lumbar spine fusion surgery |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
(1)腰椎退行性病变引起的疼痛或功能障碍,保守治疗无效,严重影响日常工作和生活; (2)患者及家属选择腰椎后路融合术; (3)术前评估能耐受手术,无手术禁忌症。 (4)手术出血小于200ml,手术时间小于90min (5)年龄≥45岁,≤60岁。 |
||||||||||||||||||||||
|
Inclusion criteria |
(1) Pain or dysfunction caused by degenerative lumbar spine disease, ineffective conservative treatment, and seriously affecting daily work and life; (2) Patients and their families choose posterior lumbar fusion; (3) Preoperative assessment can tolerate the surgery and there is no contraindication to surgery. (4) Surgical bleeding is less than 200 ml, and surgical time is less than 90 min. (5) Age ≥45 years old and ≤60 years old. |
||||||||||||||||||||||
|
排除标准: |
(1)术前已经出现马尾神经损伤患者; (2)二次行腰椎融合术或翻修等; (3)术中出现硬膜囊撕裂,脑脊液漏; (4)身体任何部位的活动性及隐匿感染; (5)严重精神或认知障碍; (6)恶性肿瘤晚期。 |
||||||||||||||||||||||
|
Exclusion criteria: |
(1) Patients with preoperative cauda equina injury already present; (2) Secondary lumbar fusion or revision, etc; (3) Intraoperative dural sac tears and cerebrospinal fluid leaks; (4) Active and occult infections in any part of the body; (5) Severe mental or cognitive impairment; (6) Advanced malignant tumors. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-01-01 00:00:00至 To 2023-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2023-01-01 00:00:00 至 To 2023-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
采用简单随机化分组方法,用 SPSS 22.0 软件产生随机数字,按照纳入先后顺序把患者随机分为 2 组(对照组、康复组) |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The patients were randomly divided into 2 groups (control group and rehabilitation group) according to the order of inclusion, and SPSS 22.0 software was used to generate random numbers |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
以网络平台的方式公布原始数据,公布时间为2025年6月。(ResMan, http://www.medresman.org.cn/login.aspx) |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Publication of raw data in the form of a web-based platform with a publication date of June 2025.(ResMan, http://www.medresman.org.cn/login.aspx) |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
①数据的可溯源性、病例报告表(CRF)的填写与移交 最原始记录为住院病历。病例报告表来自病历,由研究者填写,每个入选病例必须完成病例报告表。完成的病例报告表由临床监察员审查后,第一联交数据统计单位,进行数据录入与管理工作。第一联移交后,病例报告表的内容不再作修改。 ②数据的录入与修改 数据录入与管理由统计单位数据管理员负责。采用SPSS专用数据库,进行数据录入与管理。为保证数据的准确性,应由两个数据管理员独立进行双份录入并校对。 对病例报告表中存在的疑问。数据管理员将填写疑问解答表(DRO),并通过临床监查员向研究者发出询问,研究者应以书面答询方式尽快解答并返回,数据管理员根据研究者的回答进行数据修改,确认与录入,必要时可以再次发出DRO。 ③数据的锁定 在盲态审核并确认建立的数据库正确后,由主要研究者、申办者、统计分析人员和监督管理人员对数据进行锁定。锁定后的数据文件不可再做改动。数据锁定之后发现的问题,经确认后可在统计分析程序中进行修正。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
①Traceability of data, completion and transfer of case report forms (CRF) The most original record was the hospitalization medical record. The case report form comes from the medical record and is completed by the investigator, and the case report form must be completed for each enrolled case. The completed case report form is reviewed by the clinical ombudsman and the first link is handed over to the data statistics unit for data entry and management. After the first copy is handed over, no further changes will be made to the content of the case report form. Data entry and modification Data entry and management by the statistical unit data manager is responsible for. SPSS special database for data entry and management. In order to ensure the accuracy of the data, double entry and proofreading should be carried out independently by two data administrators. Doubts exist in the case report form. The data manager will fill in the question answer form (DRO) and send the inquiry to the investigator through the clinical supervisor. The investigator should answer the inquiry in writing and return as soon as possible, and the data manager will make data modification, confirmation and entry according to the investigator's answer, and the DRO can be sent again if necessary. ③Locking of data After blind auditing and confirming that the database established is correct, the data will be locked by the principal investigator, sponsor, statistical analyst and supervisory and management personnel. No further changes can be made to the data file after locking. Problems identified after data locking can be corrected in the statistical analysis program after confirmation. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |